Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 17 Hydroxy 3 Oxo 17alpha Pregna 4,6 Diene 21 Carboxylic Acid
2. 17-hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic Acid
3. Acid, 17-hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic
4. Acid, Canrenoic
5. Canrenoate Potassium
6. Canrenoate, Potassium
7. Canrenoic Acid
8. Kalium Can. Ratiopharm
9. Kalium-can.-ratiopharm
10. Sc 14266
11. Sc-14266
12. Sc14266
13. Soldactone
14. Soludactone
15. Spiroctan
1. Canrenoic Acid Potassium Salt
2. Canrenoate Potassium
3. Soldactone
4. 2181-04-6
5. Kanrenol
6. Canrenoate (potassium)
7. Canrenoic Acid Potassium
8. Potassium Aldadiene
9. Potassium Canrenoate [inn]
10. M671f9nlea
11. Canrenoate Potassium [usan]
12. Sc-14266
13. Mls002154212
14. Canrenone Free Acid Potassium Salt
15. Nsc-757789
16. Canrenoate Potassium (usan)
17. Soludactone
18. Apiroctan
19. Venactone
20. Kalii Canrenoas
21. Aldadiene-kalium
22. Kalium Canrenoat
23. Soldactone (tn)
24. Aldadiene-potassium
25. Canrenoato Potasico
26. Ncgc00017146-01
27. Prestwick_910
28. Canrenoate De Potassium
29. Aldadiene Potassium Salt
30. Aldadiene-kalium [german]
31. Unii-m671f9nlea
32. Dsstox_cid_25602
33. Dsstox_rid_80995
34. Dsstox_gsid_45602
35. Schembl49729
36. Kalii Canrenoas [inn-latin]
37. Potassium Canrenoate (jp17)
38. Mf 465a
39. Ccris 9164
40. Chembl1371200
41. Dtxsid2045602
42. Hy-b1582a
43. Canrenoato Potasico [inn-spanish]
44. Hms1568m18
45. Hms2095m18
46. Hms2235n14
47. Hms3712m18
48. Potassium Canrenoate [jan]
49. Einecs 218-554-9
50. Tox21_110800
51. Potassium Canrenoate [mart.]
52. Canrenoate De Potassium [inn-french]
53. Potassium Canrenoate [who-dd]
54. Akos025402245
55. Ac-6875
56. Cb 8109
57. Ccg-220148
58. Nsc 757789
59. Sc 14266
60. Smr001233495
61. Cas-2181-04-6
62. Cs-0013479
63. Canrenone Free Acid Potassium Salt [mi]
64. D01943
65. Q3655600
66. W-107518
67. Potassium 17-hydroxy-3-oxo-17-alpha-pregna-4,6-diene-21-carboxylate
68. Potassium 17-hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylate
69. Potassium 3-(17-beta-hydroxy-3-oxoandrosta-4,6-dien-17-yl)propionate
70. 17-alpha-pregna-4,6-diene-21-carboxylic Acid, 17-hydroxy-3-oxo-, Monopotassium Salt
71. Potassium 17-hydroxy-3-oxo-17.alpha.-pregna-4,6-diene-21-carboxylate
72. Potassium 3-(3-oxo-17-beta-hydroxy-4,6-androstadien-17-alpha-yl)propanoate
73. Pregna-4,6-diene-21-carboxylic Acid, 17-hydroxy-3-oxo-, Monopotassium Salt (17alpha)-
74. Pregna-4,6-diene-21-carboxylic Acid, 17-hydroxy-3-oxo-, Monopotassium Salt (17.alpha.)-
| Molecular Weight | 396.6 g/mol |
|---|---|
| Molecular Formula | C22H29KO4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 396.17029089 g/mol |
| Monoisotopic Mass | 396.17029089 g/mol |
| Topological Polar Surface Area | 77.4 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 713 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Mineralocorticoid Receptor Antagonists
Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE. (See all compounds classified as Mineralocorticoid Receptor Antagonists.)
C - Cardiovascular system
C03 - Diuretics
C03D - Aldosterone antagonists and other potassium-sparing agents
C03DA - Aldosterone antagonists
C03DA02 - Potassium canrenoate
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Global Sales Information
ANALYTICAL
ABOUT THIS PAGE
A Canrenoate Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Canrenoate Potassium, including repackagers and relabelers. The FDA regulates Canrenoate Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Canrenoate Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Canrenoate Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Canrenoate Potassium supplier is an individual or a company that provides Canrenoate Potassium active pharmaceutical ingredient (API) or Canrenoate Potassium finished formulations upon request. The Canrenoate Potassium suppliers may include Canrenoate Potassium API manufacturers, exporters, distributors and traders.
click here to find a list of Canrenoate Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Canrenoate Potassium Drug Master File in Japan (Canrenoate Potassium JDMF) empowers Canrenoate Potassium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Canrenoate Potassium JDMF during the approval evaluation for pharmaceutical products. At the time of Canrenoate Potassium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Canrenoate Potassium suppliers with JDMF on PharmaCompass.
Canrenoate Potassium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Canrenoate Potassium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Canrenoate Potassium GMP manufacturer or Canrenoate Potassium GMP API supplier for your needs.
A Canrenoate Potassium CoA (Certificate of Analysis) is a formal document that attests to Canrenoate Potassium's compliance with Canrenoate Potassium specifications and serves as a tool for batch-level quality control.
Canrenoate Potassium CoA mostly includes findings from lab analyses of a specific batch. For each Canrenoate Potassium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Canrenoate Potassium may be tested according to a variety of international standards, such as European Pharmacopoeia (Canrenoate Potassium EP), Canrenoate Potassium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Canrenoate Potassium USP).
LOOKING FOR A SUPPLIER?
